TY - JOUR
T1 - Stool pattern is associated with not only the prevalence of tumorigenic bacteria isolated from fecal matter but also plasma and fecal fatty acids in healthy Japanese adults
AU - Watanabe, Daiki
AU - Murakami, Haruka
AU - Ohno, Harumi
AU - Tanisawa, Kumpei
AU - Konishi, Kana
AU - Todoroki-Mori, Kikue
AU - Tsunematsu, Yuta
AU - Sato, Michio
AU - Ogata, Yuji
AU - Miyoshi, Noriyuki
AU - Kubota, Naoto
AU - Kunisawa, Jun
AU - Wakabayashi, Keiji
AU - Kubota, Tetsuya
AU - Watanabe, Kenji
AU - Miyachi, Motohiko
N1 - Funding Information:
We are grateful to all of the participants who provided fecal samples for use in this research and to the members of the Physical Activity Research Laboratory at the National Institute of Health and Nutrition, NIBIOHN.
Funding Information:
This study was supported by the Grant-in-Aid for Scientific Research C (JP16K00944), the Health and Labor Sciences Research Grant (201709002B) to M. Miyachi, and the Development of Innovative Research on Cancer Therapeutics from Japan Agency for Medical Research and Development (16ck0106243h0001) to K. Watanabe. These funding were used for the purpose of designing the study, and for data collection and analysis.
Publisher Copyright:
© 2021, The Author(s).
PY - 2021/12
Y1 - 2021/12
N2 - Background: Colibactin-producing Escherichia coli containing polyketide synthase (pks+E. coli) has been shown to be involved in colorectal cancer (CRC) development through gut microbiota analysis in animal models. Stool status has been associated with potentially adverse gut microbiome profiles from fecal analysis in adults. We examined the association between stool patterns and the prevalence of pks+E. coli isolated from microbiota in fecal samples of 224 healthy Japanese individuals. Results: Stool patterns were determined through factorial analysis using a previously validated questionnaire that included stool frequency, volume, color, shape, and odor. Factor scores were classified into tertiles. The prevalence of pks+E. coli was determined by using specific primers for pks+E. coli in fecal samples. Plasma and fecal fatty acids were measured via gas chromatography-mass spectrometry. The prevalence of pks+E. coli was 26.8%. Three stool patterns identified by factorial analysis accounted for 70.1% of all patterns seen (factor 1: lower frequency, darker color, and harder shape; factor 2: higher volume and softer shape; and factor 3: darker color and stronger odor). Multivariable-adjusted odds ratios (95% confidence intervals) of the prevalence of pks+E. coli for the highest versus the lowest third of the factor 1 score was 3.16 (1.38 to 7.24; P for trend = 0.006). This stool pattern exhibited a significant positive correlation with fecal isobutyrate, isovalerate, valerate, and hexanoate but showed a significant negative correlation with plasma eicosenoic acid and α-linoleic acid, as well as fecal propionate and succinate. No other stool patterns were significant. Conclusions: These results suggest that stool patterns may be useful in the evaluation of the presence of tumorigenic bacteria and fecal fatty acids through self-monitoring of stool status without the requirement for specialist technology or skill. Furthermore, it may provide valuable insight about effective strategies for the early discovery of CRC.
AB - Background: Colibactin-producing Escherichia coli containing polyketide synthase (pks+E. coli) has been shown to be involved in colorectal cancer (CRC) development through gut microbiota analysis in animal models. Stool status has been associated with potentially adverse gut microbiome profiles from fecal analysis in adults. We examined the association between stool patterns and the prevalence of pks+E. coli isolated from microbiota in fecal samples of 224 healthy Japanese individuals. Results: Stool patterns were determined through factorial analysis using a previously validated questionnaire that included stool frequency, volume, color, shape, and odor. Factor scores were classified into tertiles. The prevalence of pks+E. coli was determined by using specific primers for pks+E. coli in fecal samples. Plasma and fecal fatty acids were measured via gas chromatography-mass spectrometry. The prevalence of pks+E. coli was 26.8%. Three stool patterns identified by factorial analysis accounted for 70.1% of all patterns seen (factor 1: lower frequency, darker color, and harder shape; factor 2: higher volume and softer shape; and factor 3: darker color and stronger odor). Multivariable-adjusted odds ratios (95% confidence intervals) of the prevalence of pks+E. coli for the highest versus the lowest third of the factor 1 score was 3.16 (1.38 to 7.24; P for trend = 0.006). This stool pattern exhibited a significant positive correlation with fecal isobutyrate, isovalerate, valerate, and hexanoate but showed a significant negative correlation with plasma eicosenoic acid and α-linoleic acid, as well as fecal propionate and succinate. No other stool patterns were significant. Conclusions: These results suggest that stool patterns may be useful in the evaluation of the presence of tumorigenic bacteria and fecal fatty acids through self-monitoring of stool status without the requirement for specialist technology or skill. Furthermore, it may provide valuable insight about effective strategies for the early discovery of CRC.
KW - Cross-sectional study
KW - Fatty acid
KW - Stool pattern
KW - Tumorigenic bacteria
UR - http://www.scopus.com/inward/record.url?scp=85109589493&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85109589493&partnerID=8YFLogxK
U2 - 10.1186/s12866-021-02255-6
DO - 10.1186/s12866-021-02255-6
M3 - Article
C2 - 34182940
AN - SCOPUS:85109589493
SN - 1471-2180
VL - 21
JO - BMC Microbiology
JF - BMC Microbiology
IS - 1
M1 - 196
ER -